AC BioTech

Effectively treating solid hypoxic cancers

A French clinical-stage company with a ground breaking life-prolonging treatment of pancreatic cancer. Clinical trials Phase 2a to start in early 2024.

About us

AC Biotech is a French biotech start-up company headquartered at the Villejuif Bio Park in Paris.


Our medical objective is to validate and bring to clinical use, a novel approach to improve the treatment of metastatic pancreatic adenocarcinoma.


Archive of publications resulting from our research.